Free tool
Diagnostics stocks
We cover 56 companies grouped under the Diagnostics theme. The median market value in the group is $164.70M. Across the group, the median move over the past trading day is +0.91%. 55% of the 55 with a 200-day average trade above it. Price change over the past year runs from −84.0% to +155.5% across the middle 80 percent of the group, with a median of −8.0%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
56 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| NTRA | Natera, Inc. | $336.71 | +30.49% | +47.14% | +107.24% |
| LH | Labcorp Holdings Inc. | $337.68 | +12.12% | +34.52% | +23.25% |
| DGX | Quest Diagnostics Incorporated | $244.51 | +5.46% | +41.95% | +38.70% |
| GH | Guardant Health, Inc. | $164.92 | +13.37% | +62.10% | +166.52% |
| TEM | Tempus AI, Inc. | $68.73 | +60.17% | +10.21% | −9.45% |
| QGEN | Qiagen N.V. | $43.65 | +6.26% | −3.41% | −10.74% |
| CAI | Caris Life Sciences, Inc. | $28.01 | +79.21% | +3.82% | −27.21% |
| BLLN | BillionToOne, Inc. | $100.08 | −21.80% | +12.08% | −8.14% |
| ADPT | Adaptive Biotechnologies Corporation | $26.25 | +16.46% | +64.99% | +107.18% |
| GRAL | GRAIL, Inc. | $82.54 | +23.62% | −7.12% | +150.69% |
| VCYT | Veracyte, Inc. Common Stock | $44.04 | −20.81% | +3.89% | +49.04% |
| CDNA | CareDx, Inc. | $50.80 | +39.71% | +165.41% | +298.43% |
| WGS | GeneDx Holdings Corp. | $87.41 | +44.38% | −33.93% | −28.28% |
| NEOG | Neogen Corporation | $11.64 | +24.63% | +66.29% | +107.86% |
| NEO | NeoGenomics, Inc. | $16.79 | +27.78% | +42.77% | +160.31% |
| PSNL | Personalis, Inc. | $17.25 | +43.99% | +119.75% | +267.02% |
| OPK | OPKO Health, Inc. | $1.49 | +20.16% | +17.32% | +7.19% |
| QDEL | QuidelOrtho Corporation | $15.05 | −10.58% | −47.71% | −45.57% |
| CSTL | Castle Biosciences, Inc. | $35.00 | +43.21% | −9.19% | +70.15% |
| DASA3.SA | Diagnósticos da América S.A. | 2.62 BRL | −8.07% | −41.52% | +111.29% |
| FLGT | Fulgent Genetics, Inc. | $19.95 | +1.89% | −22.04% | −7.34% |
| NNNN | Anbio Biotechnology | $7.83 | −23.08% | −73.44% | −84.06% |
| YDES | YD Bio Ltd | $4.68 | +104.37% | −61.00% | −64.97% |
| BDSX | Biodesix, Inc. | $28.08 | +26.35% | +334.60% | +186.48% |
| MYGN | Myriad Genetics, Inc. | $3.19 | −41.47% | −48.05% | −45.84% |
| OSUR | OraSure Technologies, Inc. | $3.78 | −4.55% | +58.82% | +20.38% |
| LUCD | Lucid Diagnostics Inc. | $1.01 | +11.85% | −9.82% | −12.93% |
| XGN | Exagen Inc. | $7.60 | +72.73% | +25.83% | −22.84% |
| IMDX | Insight Molecular Diagnostics Inc. | $4.44 | −5.53% | −37.99% | +78.31% |
| PCSC | Perceptive Capital Solutions Corp | $11.95 | +0.67% | −8.08% | +13.16% |
| QUCY | Quantum Cyber N.V. | $1.36 | +23.64% | +17.24% | −20.93% |
| BNR | Burning Rock Biotech Limited | $9.80 | +4.26% | −50.20% | +13.95% |
| AALR3.SA | Alliança Saúde e Participações S.A. | 2.95 BRL | −8.39% | −36.56% | −52.27% |
| SERA | Sera Prognostics, Inc. | $2.18 | +6.34% | −27.33% | −17.42% |
| MDXH | MDxHealth SA | $0.79 | +88.71% | −77.00% | −83.84% |
| KVAC | Keen Vision Acquisition Corp | $12.01 | −6.17% | +2.21% | +4.43% |
| DXR | Daxor Corporation | $10.00 | −2.06% | −30.36% | −7.83% |
| PRPO | Precipio, Inc. | $30.85 | +34.60% | +29.51% | +117.41% |
| RIBB | Ribbon Acquisition Corp. | $10.88 | +0.51% | +4.97% | +6.62% |
| PAVM | PAVmed Inc. | $5.28 | +1.44% | −28.04% | −64.04% |
| MBX.TO | Microbix Biosystems Inc. | 0.30 CAD | −3.23% | +25.00% | +25.00% |
| ADVB | Advanced Biomed Inc. | $9.18 | −36.07% | +51.99% | −4.38% |
| CODX | Co-Diagnostics, Inc. | $1.23 | −39.71% | −77.88% | −87.07% |
| ACON | Aclarion, Inc. | $2.49 | +12.16% | −50.00% | −65.89% |
| INBS | Intelligent Bio Solutions Inc. | $2.36 | +37.21% | −70.09% | −83.95% |
| NDRA | ENDRA Life Sciences Inc. | $4.75 | −0.63% | +10.72% | +6.74% |
| AIDX | 20/20 Biolabs, Inc. | $0.53 | +17.38% | −97.79% | −97.79% |
| CDIO | Cardio Diagnostics Holdings, Inc. | $1.91 | +17.90% | −32.75% | −45.58% |
| BMRA | Biomerica, Inc. | $1.77 | +9.26% | −30.04% | −48.40% |
| VNRX | VolitionRx Limited | $0.38 | −56.30% | −92.88% | −97.21% |
| BGLC | BioNexus Gene Lab Corp. | $1.55 | +13.14% | −60.66% | −72.52% |
| REVB | Revelation Biosciences, Inc. | $1.00 | −5.66% | −69.25% | −91.21% |
| BIAF | bioAffinity Technologies, Inc. | $5.19 | +661.00% | +325.41% | −30.52% |
| ONCO | Onconetix, Inc. | $0.64 | −21.01% | −99.20% | −99.57% |
| VRAX | Virax Biolabs Group Limited | $2.91 | −6.13% | +657.81% | +275.97% |
| BJDX | Bluejay Diagnostics, Inc. | $0.92 | −16.71% | −65.03% | −83.87% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.